Holocene Advisors’s MacroGenics MGNX Stock Holding History

Holocene Advisors’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,500,096	Closed	-$40.3M	–	910
2021 Q2	$40.3M	Buy	+1,500,096	New	+$43.9M	0.23%	139

Other funds holding MGNX

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Holocene Advisors's MGNX Position: Q3 2021 in Review

Holocene Advisors sold out of MacroGenics (MGNX) in Q3 2021, closing a stake of 1,500,096 shares — an estimated $40.3M sold.

Holocene Advisors first reported a position in MGNX in Q2 2021 and held it in 1 quarter. The position peaked at $40.3M in Q2 2021. 154 funds tracked by Wall St. Rank hold MGNX as of Q3 2021.

Holocene Advisors reported no remaining MacroGenics position as of Q3 2021 after selling out during the quarter.
Holocene Advisors sold 1,500,096 MacroGenics shares in Q3 2021, an estimated $40.3M.
Holocene Advisors first reported a position in MacroGenics in Q2 2021 and held it in 1 quarter.
Holocene Advisors's MacroGenics position peaked at $40.3M in Q2 2021.
154 funds tracked by Wall St. Rank held MacroGenics as of Q3 2021.

Based on Holocene Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.